Heparin affinity high-performance liquid chromatography as an alternative to bioassay of CS23 mutein of recombinant human basic fibroblast growth factor

Yakugaku Zasshi

Volumn 116, Issue 12, 1996, Pages 951-960

  Hiroshima, Takashi ^a   Higashi, Atsuya ^a   Imamoto, Tsuyoshi ^a   Kusumoto, Shunji ^a   Itakura, Koichi ^a   Nishijima, Koji ^a   Nishi, Kiyoshi ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

bioassay; biological activity; CS23 mutein; heparin affinity HPLC; recombinant human basic fibroblast growth factor

Indexed keywords

HEPARIN; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

ARTICLE; BIOASSAY; DRUG ACTIVITY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; QUALITY CONTROL;

EID: 0030456003     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi1947.116.12_951     Document Type: Article

References (14)

1. Gospodarowicz D., Nature (London), 249, 123-127 (1974).
2. SCRIP No. 1559, Oct., 19th, 1990, p. 25.
3. Szabo S., Vattay P., Morales R. E., Johnson B., Kato K., Folkman J., Dig. Dis. Sci., 34, 1311-1323 (1989).
4. Kurokawa T., Sasada R., Iwane M., Igarashi K., FEBS Lett., 213, 186-194 (1987).
5. Iwane M., Kurokawa T., Sasada R., Seno M., Makagawa S., Igarashi K., Biochem. Biophys. Res. Commun., 146, 470-477 (1987).
6. Seno M., Sasada R., Iwane M., Sudo K., Kurokawa T., Ito K., Igarashi K., Biochem. Biophys. Res. Commun., 151, 701-708 (1987).
7. Burgess W. H., Maciag T., Ann. Rev. Biochem., 58, 575-606 (1989).
8. Kajio T., Kawahara K., Kato K., JPM, 28, 9-14 (1992).
9. Frelinger A. L., Zull J. E., J. Bio. Chem., 259, 5507-5513 (1984).
10. Ago H., Kitagawa Y., Fujishima A., Matsuura Y., Katsube Y., J. Biochem., 110, 360-363 (1991).